Value in Litigation & Implications for Litigation Finance

By John Freund |

The following article is part of an ongoing column titled ‘Investor Insights.’ 

Brought to you by Ed Truant, founder and content manager of Slingshot Capital, ‘Investor Insights’ will provide thoughtful and engaging perspectives on all aspects of investing in litigation finance. 

Executive Summary

  • 3 Phases of Risk:
    • De-Risking
    • Optimum Resolution
    • Re-Risking
  • Optimum risk-adjusted zone is when information is maximized and trial has yet to begin
  • Once a trial begins, outcomes become binary in the absence of a settlement
  • Diversification is critical to investing in the litigation finance sector

Investor Insights

  • In assessing portfolio performance, it’s crucial to determine the extent of trial outcomes
  • Assess settlement performance in the context of industry settlement rates
  • Generally, a high percentage of cases are settled
  • Certain case types have lower settlement rates, so there is not a ‘one size fits all’ approach to analyzing portfolio performance

I was speaking recently with a local litigation finance manager about the value of a piece of litigation in the context of litigation finance.  As I thought more about the discussion and the implications for settlements and maximizing outcomes, I felt compelled to relay the thoughts in an article for other industry participants to consider and argue.  Keep in mind that this is a simplistic view of a piece of litigation, as most litigation has layers of complexity that influence valuation, not to mention precedents in other jurisdictions.

Value

The intrinsic value of a piece of litigation is made up of a number of components that lawyers, plaintiffs and litigation finance managers assess as they underwrite their investment decision, which typically consist of the following:

merits of the casedefense counsel effectiveness
collectability of damagesdefendant’s conduct re: previous litigation
quantum of damagesplaintiff counsel effectiveness
justice considerations (judiciary and jurisdiction)

For the purposes of this article, we will mainly reference early stage, pre-settlement cases.

Editor’s note– the following contribution appears with illustrative graphs and charts here.  

Value is not a static concept in litigation.  Nevertheless, litigation fund managers have to determine approximate value; or a value range at the very early stages of a case when there is a relatively high degree of uncertainty, relatively few facts and little to nothing in terms of judicial proceedings.  In the context of litigation, value varies with time (while time may add value in the short term by virtue of contributing to the amount of information that can be gathered on the case, the longer a case drags on past the point where maximum information is available, the less valuable time becomes due to the time value of money). Value also varies proportionately – or perhaps disproportionately – with risk, which is in turn influenced by information. That is to say, unknown data may come to light that becomes beneficial or harmful to the merits of your case and may influence its outcome and/or quantum. As an example, the ‘certification’ process of a class action in certain jurisdictions has a meaningful impact on whether the class proceeds with the action, and ultimately is a strong determinant of success, typically through settlement.

Of course, in all jurisdictions, another major contributing factor is access to capital so plaintiffs can finance the pursuit of their meritorious claims to the point of collection of damages – enter litigation finance. We will assume for the remainder of this article that all cases have the appropriate amount of financing.

As discussed, the value of a case is determined by two factors: risk and time.  All cases start where risk is at a maximum, as there is relatively little information known about the case and hence a great degree of uncertainty about its outcome. As plaintiff and counsel build their case and proceed through discovery, the case generally becomes ‘de-risked’ as the plaintiff team grows more comfortable about the merits of their case and the quantum of damages. As we move through the case, we enter the zone of ‘optimum resolution’. However, ‘optimum resolution’ is not necessarily a value maximizing concept, but rather a concept of risk-adjusted value maximization.  The risk-adjusted aspect stems from the fact that both sides have about equal information concerning the dispute, and are now able to make a rational decision as to the possible outcomes and damage quantification. At the point where the process moves past the Optimum Resolution phase, the parties enter into a new phase of risk which is reflective of the binary risk nature of litigation, whereby the outcome is determined by a third party judiciary.

As the plaintiff gathers more information regarding his or her case, the case generally increases in value as risk diminishes.  However, at the point where a judicial process commences (and assuming a settlement doesn’t occur between the start of the process and the decision), the investment bifurcates into two potential outcomes on the assumption that there is no resolution after the start of the trial – generally, either a win or a loss outcome.  In certain jurisdictions where they have “adverse costs” or “loser pays” rules, the plaintiff will have to pay the defense costs, and so there is a real financial cost in addition to the lost opportunity associated with a positive outcome. 

Implications

The purpose of this analysis is to focus the plaintiff on the fact that on a risk-adjusted basis, the zone of Optimum Resolution is the most advantageous point in the litigation process to resolve the case, as it reflects the point of most knowledge and least risk.  This is the point in time to cast aside all emotional elements of the case and the impact of damages incurred, and focus on a realistic outcome that can be achieved through negotiation and settlement, regardless of whether it makes the plaintiff “whole” or not.  Of course, as the old saying goes, “it takes two to tango”, and so, if the defense is not of the same opinion, or their analysis is skewed, they may have a very different perspective on the appropriate settlement amount.  In the case of insurance companies as defendants in cases, they may have other considerations such as statutory reserve requirements or corporate strategic reasons to delay as long as possible (time value of money and the impact on their insurance reserves and investment returns).  Nevertheless, the concept applies to both defense and plaintiff, which is the reason for high settlement rates in most litigation in all jurisdictions.

From an investor’s perspective, there should be a recognition that as each case in their portfolio extends beyond the zone of Optimum Resolution, the risk to their portfolio increases.  Accordingly, if you are an institutional investor buying a secondary pool of litigation finance assets, you want to be sure you are not buying a series of old cases where the binary risk is high and you are not getting an appropriate discount to assume the risk.  Of course, there are always exceptions to this rule.  The reason a case has extended for a long period of time may be because the plaintiff has had successive wins at various levels of judiciary and the risk has started to shift away from binary litigation risk toward collection and enforcement risk (Burford’s investment in the ‘Petersen claim’ is a prime example of this phenomenon).

Needless to say, litigation is not a formulaic science, and because of the large degree of human interaction and case complexity, it will be relegated into the “arts” category for the time being.  Perhaps artificial intelligence can add a scientific element to determining value and litigation outcomes, but until the vast knowledge of settlement data becomes publicly available, the industry will depend on ‘gut instinct’ and litigation experience in making its decisions.  From an investment perspective, the important point is that diversification is critical to capture the upside inherent in the asset class, while minimizing the downside inherent in the inevitable losses that will be experienced.

Important Considerations 

Other important factors to consider are the use of contingent fee arrangements and litigation finance, and the impact those characteristics have on the ultimate value of a piece of litigation.  Some in the litigation finance community will argue that they will only consider providing financing to cases where the lawyer is providing their services on a 100% contingent basis (there could be jurisdiction specific constraints to the use of contingent fee arrangements), as this fosters alignment between plaintiff and lawyer to maximize the value of the claim.  Certainly, the alignment argument makes intuitive sense.  However, not every funder is convinced of this fact, and unfortunately, there is not a broad set of data that is definitive in this regard.  Accordingly, until the data determines there is a strong correlation between contingent fee arrangements and outcomes, it remains to be seen.  On one of the panels at the September 2019 LF Dealmakers conference, a litigation funder stated that the company’s empirical data suggests there is no correlation, and hence contingency fee arrangements are not a significant feature to their underwriting process. Yet it’s worth pointing out that many funders feel strongly that the alignment argument is a good one, so they refuse to invest in a case without at least some level of legal counsel fee contingency.

Then there is the existence and use of litigation funding itself.  One could argue that the very existence of a plaintiff’s use of a litigation funder to pursue its case will shift the balance of power and ‘level the playing field’ between the plaintiff and the defendant, especially in a David v. Goliath situation where the defendant is ‘deep pocketed’ and the plaintiff relatively impecunious.  As an investor in the industry, not only do I subscribe to the theory, I have seen the results.  While many would suggest it is difficult to parse the effect of litigation funding from the effect of good legal representation and a meritorious claim, I look at the results of relatively small financings and I can see a correlation between success and short duration, which I, in large part, ascribe to the existence of litigation finance.

Investor Insights:

As a consequence of the above, when I review track records for fund managers one of the metrics I look at is how often the realized outcomes are dependent on a judicial decision (bench, trial or arbitral) as compared to an outcome determined through settlement.  Overall, the data concerning litigation outcomes illustrates that a high percentage of cases (90%+) are settled prior to a judicial decision and so we need to view the results in the context of industry settlement rates. Generally speaking, and depending on the case type and jurisdiction, I have a strong preference for fund managers that have a disproportionate number of settlements in their realized portfolios as opposed to outcomes that were derived from a judicial decision, given the binary nature of those outcomes.  In certain jurisdictions, litigation funders are able to have some influence on the settlement discussions which may tend to favour higher settlement rates, so this issue and my approach to it is not identical in every jurisdiction.  Another influencing factor on settlement rates is case types and case sizes.  Generally speaking, I have noticed that outcomes dependent on judicial/arbitral decisions are correlated with larger cases and certain case types (as an example, International Arbitration cases would be one area where settlement is less likely and hence arbitral outcomes more prevalent).

Edward Truant is the founder of Slingshot Capital Inc., and an investor in the consumer and commercial litigation finance industry.

Commercial

View All

The Dangers of Retrospective Legislation in Litigation Funding

By John Freund |

The debate around whether the Litigation Funding Agreements (Enforceability) Bill should be retrospective is a complex one, with valid arguments on both sides. A recent op-ed makes the case that retrospectivity poses significant dangers and unfairness.

Writing in LegalFutures, Jeremy Marshall, Chief Investment Officer of Winward UK, argues that the core issue is whether it is unfair to allow litigation funders to rely on contractual agreements that were freely entered into by both parties, even if those agreements were based on a mistake of law.

Marshall claims that the common law right to recover money paid under a mistake only applies when the mistake led to one party receiving an unintended benefit. In the case of litigation funding, the only benefit that has accrued is the one that was explicitly drafted into the contract. Allowing retrospectivity would open the door to satellite litigation and unreal counterfactuals, according to Marshall.

Claimants who have already received funding and won their cases are now arguing for the "right" to renegotiate and keep all the proceeds for themselves. But what about the funders' arguments that cases may have gone on longer or become more expensive than intended? Fairness demands that both sides' positions be considered.

Marshall insists that the true drawback in retrospectivity is the inherent danger of prejudicing one party to the exclusion of the other, or conferring an unexpected benefit to one party at the expense of the other. Ironically, this is precisely what those challenging the bill are attempting to do. So while the debate is a complex one, one can make a compelling case that retrospectivity in litigation funding poses significant dangers and unfairness.

ReplyForward

The CJC’s Review of Litigation Funding Will Have Far-Reaching Effects

By John Freund |

The following is a contributed piece by Tom Webster, Chief Commercial Officer at Sentry Funding.

Reform is on its way for the UK’s litigation funding sector, with the Civil Justice Council firing the starting gun on its review of litigation funding on 23 April.

The advisory body set out the terms of reference for its review, commissioned by lord chancellor Alex Chalk, and revealed the members of its core working group.

The review is working to an ambitious timetable with the aim of publishing an interim report by this summer, and a full report by summer 2025. It will be based on the CJC’s function of making civil justice ‘more accessible, fair and efficient’.

The CJC said it will set out ‘clear recommendations’ for reform in some areas. This includes consideration of a number of issues that could prove very significant for funders and clients. These include:

  • Whether the sector should be regulated, and if so, how and by whom;
  • Whether funders’ returns should be subject to a cap; and if so, to what extent;
  • The relationship between third party funding and litigation costs;
  • The court’s role in controlling the conduct of funded litigation, including the protection of claimants and ‘the interaction between pre-action and post-commencement funding of disputes’;
  • Duties relating to the provision of funding, including potential conflicts of interest between funders, lawyers and clients;
  • Whether funding encourages ‘specific litigation behaviour’ such as collective action.

The review’s core working group will be co-chaired by CJC members Mr Justice Simon Picken, a Commercial Court judge, and barrister Dr John Sorabji. The four other members are:

  • High Court judge Mrs Justice Sara Cockerill, who was judge in charge of the commercial court 2020 – 2022, and who is currently involved in a project on third party funding for the European Law Institute;
  • Academic and former City lawyer Prof Chris Hodges, chair of independent body the Regulatory Horizons Council which was set up to ensure that UK regulation keeps pace with innovation;
  • Lucy Castledine, Director of Consumer Investments at the Financial Conduct Authority; and
  • Nick Bacon KC, a prominent barrister and funding expert who acts for both claimants and defendants

The CJC had said that it may also bring in a consumer representative, as well as a solicitor experienced in group litigation.

In a sign that the review seeks to be informed by a wide range of views, the CJC has also extended an invitation for experts to join a broader consultation group, which will directly inform the work of the review and provide a larger forum for expert discussion. Meanwhile the advisory body has said there will also be further chance ‘for all to engage formally with this review’ later this year.

Given the broad remit of the review and significant impact that its recommendations may have on the litigation funding industry, litigation funders, lawyers and clients would be well advised to make the most of these opportunities to contribute to the review.

Read More

Balancing Risk and Reward in Litigation Finance: Lessons from High-Profile Case

By John Freund |

The following is a contributed piece by Jeff Manley, Chief Operating Officer of Armadillo Litigation Funding.

The allure of substantial returns from mass tort litigation has historically tempted law firms and their third-party financiers to commit resources to speculative cases. While investing strongly in speculative torts certainly has its time and place, prevailing trends highlight the necessity of certain risk management practices. The unpredictable outcomes of high-profile cases, like the Camp LeJeune water contamination lawsuits, accentuate the imperative for a discerning approach to case selection and the strategic diversification of portfolios.

Balancing Opportunity and Prudence in Speculative Torts

Early-stage speculative torts like the Zantac litigation represent a blend of potential and caution. (In re Zantac (Ranitidine) Products Liability Litigation, 2021). Initially, Zantac cases drew significant attention from law firms with projections of substantial compensation figures. However, the legal complexities and subsequent valuation adjustments highlighted the disparity between initial projections and actual compensation figures realized, reinforcing the need for meticulous risk assessment in speculative torts. While similar cases have captivated law firms and financiers with their substantial projections, they also underscore the importance of an exhaustive risk assessment—demonstrating how initial excitement must be tempered with diligent legal analysis and realistic valuation adjustments.

Navigating the Complex Terrain of Camp Lejeune Litigation

The Camp Lejeune water contamination lawsuits represent promising ventures for financiers and mass tort firms to affirm their moral duty by advocating for those who served our country. However, these cases also carry lessons on the pitfalls of overzealous investment without careful scrutiny. The drawn-out nature of the litigation serves as a reminder that while the pursuit of justice is noble, it must be balanced with sound risk management to ensure long term firm stability.

Endurance in Talc Litigation: A Testament to Long-Term Vision

The protracted legal battles surrounding talcum powder’s health risks underscore the necessity for long-term strategic planning in mass tort litigation. Firms must factor in the operational demands and the financial foresight to manage compounded interest on borrowed capital over extensive periods. Simultaneously, it’s critical to sustain investment in new torts, ensuring a balanced portfolio that accommodates both ongoing cases and emerging opportunities. This balanced approach underpins the stamina needed to endure through a decade-long commitment, as exemplified by the talc litigation.

Understanding Returns in the 3M Earplug Litigation

The 3M earplug litigation concluded within a standard timeframe, yet the distribution of settlements spans several years, offering more modest financial returns than many anticipated. This outcome serves as a pragmatic reminder of the nuanced nature of mass tort settlements, where significant payouts are not always immediate or as substantial as predicted. Nonetheless, this reinforces the value of prudent risk management strategies that account for longer payout terms, ensuring a stable financial forecast and the firm's resilience in the face of lower-than-expected returns.

Strategic Portfolio Diversification

Given these varied experiences, it is imperative that law firm owners and financial backers craft a robust case portfolio strategy. By balancing the mix of cases from speculative to those with a more established settlement trajectory, firms can better manage risk and ensure operational stability. Strategic diversification is not just wise—it’s a vital tactic to maintain resilience in the evolving landscape of the mass tort industry.

The Value of Expert Financial Partnerships

Choosing a reputable and experienced litigation finance partner is essential for law firms aiming to effectively balance their case portfolios. A seasoned funding partner provides invaluable guidance in evaluating potential cases, assessing financial risks, and optimizing investment strategies. Their expertise in navigating the nuanced terrain of litigation finance is a critical asset.

Adopting a balanced portfolio strategy—carefully curated to include a variety of torts at different development stages—provides a more stable foundation than pursuing an "all-in" strategy on a single high-potential tort. This method not only reduces dependency on the success of any single case but also positions the firm more favorably in the eyes of prudent lenders.

Recent high-profile cases in the mass tort arena, like those mentioned above, serve as potent reminders of the inherent uncertainties in litigation finance. For law firm owners and their financial backers, the path forward demands a nuanced view of risk, underscored by strategic portfolio diversification and the cultivation of partnerships with experienced financing entities. By adopting these principles, stakeholders can safeguard their investments against the capricious nature of mass litigation, securing a resilient and prosperous future in the challenging yet rewarding domain of legal finance.

Read More